Association for Accessible Medicines
601 New Jersey Ave NW, Suite 850
Washington, DC 20001
E: [email protected]
Dr. Ripen Misri obtained his PhD in pharmaceutical sciences from the University of British Columbia (Canada) and further pursued a post doctoral fellowship at BC Cancer Research Center. Dr. Misri’s expertise is in development of complex dosage forms such as nanoparticulate and microparticulate drug delivery systems, inhalation products and peptide therapeutics. Dr. Misri joined Apotex in 2015 and is currently Senior Director of Liquids & Specialty Dosage Forms, leading development of complex generic drug, and drug device combination products.